Metastatic Urothelial Carcinoma Market Growth – at a CAGR of 17.9% by 2028
Increasing geriatric population and rising prevalence of metastatic urothelial carcinoma worldwide are among the key factors driving the global Metastatic Urothelial Carcinoma market revenue growth.
Emergen Research has published its latest report titled “Metastatic Urothelial Carcinoma Market, By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Intravesical Therapy), By Diagnosis (Urine Lab Tests, Cystoscopy, Intravenous pyelogram, Biopsy), By End-use (Hospitals, Oncology Clinics, Research Institutes, Others), and By Region Forecast to 2028”
According to Emergen Research, the global metastatic urothelial carcinoma market size was USD 855.83 million in 2020 and is expected to reach USD 3.19 billion in 2028 and register a revenue CAGR of 17.9% during the forecast period, 2021-2028.
Major factors providing impetus to the global metastatic urothelial carcinoma market revenue growth are rise in global geriatric population, growing prevalence of metastatic urothelial carcinoma across the globe, and increasing cancer metastasis research & development programs. Metastatic urothelial carcinoma is one of most prevalent types of cancer in the world. Advancements in the field of genetics, rising awareness of early cancer detection and treatment, emergence of technologically advanced cancer cell imaging and detection techniques, rising cases of different type of bladder cancer – most commonly, squamous cell carcinoma in many Western parts of the world – and technological advancements in surgical techniques and equipment are among the other major factors expected to boost the global metastatic urothelial carcinoma market revenue growth over the forecast period.
Moreover, increasing investments in research & development of advanced drugs & therapeutics for metastatic urothelial carcinoma, growing demand for new and more advanced biomarkers, continuous advancements in immunotherapy, and increasing research collaborations between leading healthcare institutions and research centers further boost the global market revenue growth.
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Immunotherapy Segment Accounted for Largest Revenue Share in 2020:
Based on treatment, the global metastatic urothelial carcinoma market is segmented into Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, and Intravesical Therapy. The immunotherapy segment dominated other segments in terms of revenue share in the global market in 2020. Increasing geriatric population, rising cases of metastatic urothelial carcinoma, rapidly growing patient pool, and significant advancements in immunotherapy are among the major factors driving revenue growth of this segment.
Oncology Clinics Segment to Account for Fastest Revenue CAGR:
Based on end-use, the global metastatic urothelial carcinoma market is segmented into Hospitals, Oncology Clinics, Research Institutes, and Others. The oncology clinics segment is expected to register the fastest revenue growth rate in the global market over the forecast period. Increasing prevalence of bladder cancer, cases of metastatic urothelial carcinoma, unhealthy lifestyles of the population, and rapid adoption of advanced therapies and equipment for metastatic urothelial carcinoma treatment in hospitals and oncology clinics are key factors supporting revenue growth of this segment.
North America Accounted for Largest Revenue Share in 2020:
Among regional markets, the North America metastatic urothelial carcinoma market held the largest revenue share in the global market in 2020. Factors contributing to the regional market revenue growth are growing prevalence of metastatic urothelial carcinoma, increasing geriatric population, growing availability of high-end, advanced solutions for bladder cancer treatment, increasing healthcare expenditure in the region, and presence of leading market players such as AstraZeneca, Bristol-Myers Squibb, and Pfizer Inc.
Major Companies in the Global Metastatic Urothelial Carcinoma Market Include:
- Roche Holding AG
- Merck KGaA
- Bristol-Myers Squibb
- Johnson & Johnson Services Inc.
- Pfizer Inc.
For the purpose of this report, Emergen Research has segmented the global metastatic urothelial carcinoma market on the basis of treatment, diagnosis, end-use, and region:
Treatment Outlook (Revenue, USD Billion; 2018-2028)
- Targeted Therapy
- Radiation Therapy
- Intravesical Therapy
Diagnosis Outlook (Revenue, USD Billion; 2018-2028)
- Urine Lab Tests
- Intravenous pyelogram (IVP)
End-use Outlook (Revenue, USD Billion; 2018-2028)
- Oncology Clinics
- Research Institutes
Region Outlook (Revenue, USD Billion; 2018-2028)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Xanthan Gum Market By Form (Liquid, Dry), By Application (Stabilizer, Thickener, Gelling Agent, Coating Material, Fat Replacer), By Industry Vertical (Food & Beverages, Pharmaceutical, Oil & Gas, Cosmetic & Personal Care), and By Region Forecast to 2028.
Lightweight Materials Market, By Product Type (Plastics, Metals, Composites, Elastomers), By Distribution Channel (Direct, Indirect), By Application (Automotive, Aerospace, Energy, Marine), and By Region Forecast to 2028.
Biorational Product Market, By Type (Insecticides, Fungicides, and Nematicides), By Source (Botanical, Microbial, and Non-Organic), By Mode of Application (Foliar Spray, Soil treatment, and Trunk Injection), and By Region Forecast to 2028.
Optically Clear Adhesive Market By Resin Type (Polyvinyl Acetate, Acrylic, Polyurethane, Epoxy, Silicone, Others), Device Structure, Substrate, Application (Mobile Phones, Monitors & Laptop, Others), By End-Use, and By Region Forecast to 2028.
Metal Foam Market By Material (Aluminum, Copper, Titanium, Zinc, Nickel), By Product (Open Cell, Closed Cell), By Application (Floating Cities, Heat Exchangers, Anti-Intrusion Bars, Energy Absorbers), By End-Use, and By Region Forecast to 2028.
Fullerene Market By Type (C60, C70, C76, Other), By Production Method (Arc Discharge Method, CVD/CCVD Process, Laser Ablation of Graphite, Others), By Shape (Nanotubes, Bucky Balls, Nano-Rods), By End-use, and By Region Forecast to 2028
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Visit for More Insights: https://www.emergenresearch.com/insights